Medical Blog About Treatment Abroad

According to official statistics from the WHO in 2022, oncological diseases are now the cause of one in every six deaths worldwide. This has encouraged the international medical community to develop new advanced stage 4 cancer treatment methods and increase the effectiveness of the already existing ones.

Stage 4 stomach cancer is diagnosed in approximately 30,300 Americans annually, which is 1.5% of all cancers. The highest risk is for people over 55. This type of oncology presents serious challenges, but newer treatments in advanced medical centers improve outcomes. Modern therapies – like HIPEC, PIPAC, and...

Because cervical cancer affects approximately 660,000 women worldwide each year — ranking it fourth among the most common cancers in women globally — the gap between what early detection can achieve and what advanced disease requires is one of the most consequential in oncology. Early-stage disease...

Prostate cancer (PC) is the most common type of cancer in men and one of the main causes of death in developed countries of Europe and North America. The incidence of it has risen annually by 3% since 2014. Prostate cancer is the second-leading cause of death among males in the US. According to the American Cancer Society...

A stage 4 colon cancer diagnosis can be a challenge for the patient and their family. The presence of metastases indicates the spread of cancer to the distant organs, with the stage being shown in 22% of patients at the moment of diagnosis. Conventional approaches can achieve a 13% five-year survival rate, which is not much.

The central failure of conventional autoimmune treatment results is not that it lacks potency — it is that it addresses the wrong target. Immunosuppressants and corticosteroids suppress the immune system broadly to reduce symptoms, but the misfiring that causes the immune system to attack its own tissue continues...

The silence of stomach cancer in its early stages is not a clinical failure — it is a biological characteristic that consistently costs patients the window in which treatment is most effective. Over 1 million new cases are diagnosed each year globally — and approximately 770,000 deaths are attributed to the disease.

Cervical cancer is ranked as the fourth most common cancer among women. Nearly 660,000 new patients were diagnosed in 2022, with 350,000 deaths reported. Most of those lethal cases, about 94%, are observed in low- and middle-income countries because of limited access to human papillomavirus (HPV) vaccination and...